PortfoliosLab logoPortfoliosLab logo
ZTS vs. ELAN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZTS vs. ELAN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Zoetis Inc. (ZTS) and Elanco Animal Health Incorporated (ELAN). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

Returns By Period

In the year-to-date period, ZTS achieves a -4.42% return, which is significantly lower than ELAN's 4.29% return.


ZTS

1D
2.53%
1M
-2.13%
YTD
-4.42%
6M
-15.90%
1Y
-15.87%
3Y*
-9.82%
5Y*
-4.71%
10Y*
10.68%

ELAN

1D
3.51%
1M
-1.42%
YTD
4.29%
6M
16.03%
1Y
183.31%
3Y*
37.29%
5Y*
-4.53%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ZTS vs. ELAN - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
ZTS
Zoetis Inc.
-4.42%-21.75%-16.63%35.91%-39.51%48.26%25.76%55.71%-4.89%
ELAN
Elanco Animal Health Incorporated
4.29%86.87%-18.72%21.93%-56.94%-7.47%4.14%-6.60%-12.42%

Correlation

The correlation between ZTS and ELAN is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.55

Correlation (3Y)
Calculated over the trailing 3-year period

0.43

Correlation (5Y)
Calculated over the trailing 5-year period

0.48

Correlation (All Time)
Calculated using the full available price history since Sep 21, 2018

0.45

The correlation between ZTS and ELAN shifts across timeframes, from 0.43 (3 years) to 0.55 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ZTS:

$52.52B

ELAN:

$11.73B

EPS

ZTS:

$6.04

ELAN:

-$0.47

PS Ratio

ZTS:

5.60

ELAN:

2.49

PB Ratio

ZTS:

15.77

ELAN:

1.79

Total Revenue (TTM)

ZTS:

$9.47B

ELAN:

$4.72B

Gross Profit (TTM)

ZTS:

$6.67B

ELAN:

$2.59B

EBITDA (TTM)

ZTS:

$4.09B

ELAN:

$874.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZTS vs. ELAN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZTS
ZTS Risk / Return Rank: 1515
Overall Rank
ZTS Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
ZTS Sortino Ratio Rank: 1313
Sortino Ratio Rank
ZTS Omega Ratio Rank: 1212
Omega Ratio Rank
ZTS Calmar Ratio Rank: 1717
Calmar Ratio Rank
ZTS Martin Ratio Rank: 1919
Martin Ratio Rank

ELAN
ELAN Risk / Return Rank: 9797
Overall Rank
ELAN Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
ELAN Sortino Ratio Rank: 9898
Sortino Ratio Rank
ELAN Omega Ratio Rank: 9696
Omega Ratio Rank
ELAN Calmar Ratio Rank: 9797
Calmar Ratio Rank
ELAN Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZTS vs. ELAN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zoetis Inc. (ZTS) and Elanco Animal Health Incorporated (ELAN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ZTSELANDifference

Sharpe ratio

Return per unit of total volatility

-0.56

3.80

-4.36

Sortino ratio

Return per unit of downside risk

-0.60

5.17

-5.76

Omega ratio

Gain probability vs. loss probability

0.92

1.64

-0.72

Calmar ratio

Return relative to maximum drawdown

-0.61

10.19

-10.80

Martin ratio

Return relative to average drawdown

-1.03

31.02

-32.05

ZTS vs. ELAN - Sharpe Ratio Comparison

The current ZTS Sharpe Ratio is -0.56, which is lower than the ELAN Sharpe Ratio of 3.80. The chart below compares the historical Sharpe Ratios of ZTS and ELAN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading graphics...

Sharpe Ratios by Period


ZTSELANDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.56

3.80

-4.36

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.18

-0.10

-0.08

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.41

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

-0.12

+0.58

Drawdowns

ZTS vs. ELAN - Drawdown Comparison

The maximum ZTS drawdown since its inception was -52.06%, smaller than the maximum ELAN drawdown of -78.00%. Use the drawdown chart below to compare losses from any high point for ZTS and ELAN.


Loading graphics...

Drawdown Indicators


ZTSELANDifference

Max Drawdown

Largest peak-to-trough decline

-52.06%

-78.00%

+25.94%

Max Drawdown (1Y)

Largest decline over 1 year

-32.70%

-15.50%

-17.20%

Max Drawdown (5Y)

Largest decline over 5 years

-52.06%

-78.00%

+25.94%

Max Drawdown (10Y)

Largest decline over 10 years

-52.06%

Current Drawdown

Current decline from peak

-49.36%

-35.73%

-13.63%

Average Drawdown

Average peak-to-trough decline

-14.23%

-39.85%

+25.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.29%

5.09%

+14.20%

Volatility

ZTS vs. ELAN - Volatility Comparison

The current volatility for Zoetis Inc. (ZTS) is 8.64%, while Elanco Animal Health Incorporated (ELAN) has a volatility of 14.18%. This indicates that ZTS experiences smaller price fluctuations and is considered to be less risky than ELAN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ZTSELANDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.64%

14.18%

-5.54%

Volatility (6M)

Calculated over the trailing 6-month period

22.51%

25.76%

-3.25%

Volatility (1Y)

Calculated over the trailing 1-year period

28.63%

49.37%

-20.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.58%

44.54%

-17.96%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.93%

43.79%

-17.86%

Dividends

ZTS vs. ELAN - Dividend Comparison

ZTS's dividend yield for the trailing twelve months is around 1.70%, while ELAN has not paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
ZTS
Zoetis Inc.
1.70%1.59%1.06%0.76%0.89%0.41%0.48%0.50%0.59%0.58%0.71%0.69%
ELAN
Elanco Animal Health Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ZTS vs. ELAN - Financials Comparison

This section allows you to compare key financial metrics between Zoetis Inc. and Elanco Animal Health Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B1.50B2.00B2.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
2.39B
1.14B
(ZTS) Total Revenue
(ELAN) Total Revenue
Values in USD except per share items

ZTS vs. ELAN - Profitability Comparison

The chart below illustrates the profitability comparison between Zoetis Inc. and Elanco Animal Health Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
68.9%
74.6%
Portfolio components
ZTS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Zoetis Inc. reported a gross profit of 1.64B and revenue of 2.39B. Therefore, the gross margin over that period was 68.9%.

ELAN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Elanco Animal Health Incorporated reported a gross profit of 853.00M and revenue of 1.14B. Therefore, the gross margin over that period was 74.6%.

ZTS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Zoetis Inc. reported an operating income of 826.00M and revenue of 2.39B, resulting in an operating margin of 34.6%.

ELAN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Elanco Animal Health Incorporated reported an operating income of 562.00M and revenue of 1.14B, resulting in an operating margin of 49.1%.

ZTS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Zoetis Inc. reported a net income of 603.00M and revenue of 2.39B, resulting in a net margin of 25.3%.

ELAN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Elanco Animal Health Incorporated reported a net income of -276.00M and revenue of 1.14B, resulting in a net margin of -24.1%.